Literature DB >> 3693903

Production of tumor necrosis factor during murine listeriosis.

E A Havell1.   

Abstract

During a lethal murine infection with the gram-positive bacterium, Listeria monocytogenes, a factor appears in the serum that is capable of lysing certain tumor cells in vitro. The levels of this serum cytotoxic factor increase with the progression of morbidity. Neutralization of Listeria-induced cytotoxic factor activity with a monospecific antiserum to recombinant murine tumor necrosis factor (TNF) revealed that the cytotoxic factor was antigenically indistinguishable from natural TNF present in endotoxin-induced tumor necrosis serum. In contrast to a lethal infection, no TNF activity was detected in sera of mice throughout a sublethal infection. However, shortly after initiation of a sublethal infection, mice acquire a greatly enhanced capacity to produce serum TNF in response to an intravenous injection of endotoxin. Cultures of unfractionated spleen cells from mice with ongoing Listeria infections produced TNF when incubated in the absence, but not in the presence, of antibiotics. However, such antibiotic-treated cultures could be stimulated with endotoxin to produce substantially higher TNF yields than spleen cells of uninfected mice. It is also shown that intravenous infusion of anti-recombinant murine TNF IgG into sublethally infected mice results in increased Listeria proliferation in spleens and livers, and ultimately in death from an overwhelming infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3693903

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

1.  Rapid and sensitive assay of tumor necrosis factor-alpha gene transcription.

Authors:  X Zhang; J Ye; L Wang; J Manosroi; X Shi; Y Rojanasakul
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  In vitro properties of a Listeria monocytogenes bacteriophage-resistant mutant predict its efficacy as a live oral vaccine strain.

Authors:  Patricia A Spears; M Mitsu Suyemoto; Terri S Hamrick; Rebecca L Wolf; Edward A Havell; Paul E Orndorff
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

3.  The antitumour activity of the interferon inducer bropirimine is partially mediated by endogenous tumour necrosis factor alpha.

Authors:  M Scheringa; J N IJzermans; J Jeekel; R L Marquet
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Monocytes of individual human subjects display heterogeneous bacterial uptake and antilisterial activity.

Authors:  G Zerlauth; H E Chehadeh; E Maier; Z Schaff; M M Eibl; J W Mannhalter
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 6.  Innate and adaptive immune responses to Listeria monocytogenes: a short overview.

Authors:  Lauren A Zenewicz; Hao Shen
Journal:  Microbes Infect       Date:  2007-05-07       Impact factor: 2.700

7.  Human tumor necrosis factor increases the resistance against Listeria infection in mice.

Authors:  K Kato; A Nakane; T Minagawa; N Kasai; K Yamamoto; N Sato; N Tsuruoka
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

8.  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.

Authors:  D M Williams; L F Bonewald; G D Roodman; G I Byrne; D M Magee; J Schachter
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

9.  Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice.

Authors:  R D Wagner; N M Maroushek; J F Brown; C J Czuprynski
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  The two distinct phospholipases C of Listeria monocytogenes have overlapping roles in escape from a vacuole and cell-to-cell spread.

Authors:  G A Smith; H Marquis; S Jones; N C Johnston; D A Portnoy; H Goldfine
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.